The Fight Against COVID19
17.16k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| The Fight Against COVID19 | +4.56% | - | - | - |
| ^GSPC | -0.16% | +7.05% | +15.09% | +3802.85% |
14 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 143.68 | -0.19 | -0.13% | 4:00 pm GMT-5 | 7.35M | 6.71M | 378.24B |
| PFE | Pfizer Inc. | 36.53 | -0.07 | -0.19% | 4:03 pm GMT-5 | 26.47M | 33.40M | 203.05B |
| ABBV | AbbVie Inc. | 104.2 | +0.24 | +0.23% | 4:02 pm GMT-5 | 6.21M | 8.31M | 183.90B |
| SNY | Sanofi | 50.2 | +0.28 | +0.56% | 4:00 pm GMT-5 | 1.19M | 1.14M | 125.83B |
| GSK | GlaxoSmithKline plc | 37.23 | +0.14 | +0.38% | 4:00 pm GMT-5 | 3.62M | 4.42M | 92.43B |
| GILD | Gilead Sciences, Inc. | 59.5 | -0.75 | -1.24% | 4:00 pm GMT-5 | 8.06M | 9.39M | 74.59B |
| TAK | Takeda Pharmaceutical Company Limited | 17.72 | +0.11 | +0.62% | 4:00 pm GMT-5 | 1.04M | 1.16M | 55.16B |
| REGN | Regeneron Pharmaceuticals, Inc. | 508.31 | +2.21 | +0.44% | 4:00 pm GMT-5 | 693.04k | 956.74k | 54.24B |
| MRNA | Moderna, Inc. | 109.18 | +10.62 | +10.78% | 4:00 pm GMT-5 | 25.85M | 11.06M | 43.20B |
| BNTX | BioNTech SE | 104.96 | +3.09 | +3.03% | 4:00 pm GMT-5 | 3.01M | 3.08M | 25.27B |
| NVAX | Novavax, Inc. | 102.6 | +7.27 | +7.63% | 4:00 pm GMT-5 | 3.79M | 4.14M | 6.53B |
| VIR | Vir Biotechnology, Inc. | 28.41 | +1.21 | +4.45% | 4:00 pm GMT-5 | 532.05k | 1.17M | 3.62B |
| INO | Inovio Pharmaceuticals, Inc. | 10.39 | +0.24 | +2.36% | 4:00 pm GMT-5 | 11.06M | 15.94M | 1.76B |
- Reuters
Canada could approve Pfizer's COVID-19 vaccine 'around December'
Canada could approve Pfizer's COVID-19 vaccine "around December," about the same time as the United States and the European Union, a senior official at Canada's drug regulator said on Thursday. Health Canada had said previously that an approval would likely come early in the first quarter, under a new accelerated review process very similar to that in place in the United States. Pfizer and BioNTech's vaccine is most advanced in Health Canada's reviews, Supriya Sharma, senior medical adviser at Health Canada, said at a media briefing in Ottawa.
- Zacks
ETF Sectors to Bet on Positive Vaccine News
The introduction of the coronavirus vaccine is expected to help in the economic recovery, especially for sectors which have taken a hit from the social-distancing and lockdown measures.
- Investor's Business Daily
Dow Jones, Nasdaq Hit Highs Amid Coronavirus News As Tesla, Nio, Boeing Rally; Salesforce-Slack Deal Near?
The Dow Jones and Nasdaq hit record highs amid a broad stock market rally. Tesla, Nio and Boeing were notable winners. A Salesforce-Slack deal may be close.
